Education
About Us
Working with TipRanks
Follow Us
Cellectar Biosciences (CLRB)
NASDAQ:CLRB
CLRB Analyst Ratings
Moderate Buy
2 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
CLRB Stock 12 Month Forecast
Average Price Target
$12.00
▲(264.74% Upside)
| Highest Price Target$14.00 | Average Price Target$12.00 | Lowest Price Target$10.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Maxim Group
$10
Buy
203.95%
Upside
Upgraded
03/10/26
Roth MKM
$18→$14
Buy
325.53%
Upside
Reiterated
03/04/26
Oppenheimer
―
Hold
―
Reiterated
11/14/25
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Maxim Group
$10
Buy
203.95%
Upside
Upgraded
03/10/26
Roth MKM
$18→$14
Buy
325.53%
Upside
Reiterated
03/04/26
Oppenheimer
―
Hold
―
Reiterated
11/14/25
Best Analysts Covering Cellectar Biosciences
3 Months
xxx
Success Rate
2/7 ratings generated profit
Average Return
-14.16%
a xxx
rating ―
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 28.57% of your transactions generating a profit, with an average return of -14.16% per trade.
1 Year
Success Rate
2/7 ratings generated profit
Average Return
-53.19%
a rating ―
Copying Jason McCarthy's trades and holding each position for 1 Year would result in 28.57% of your transactions generating a profit, with an average return of -53.19% per trade.
2 Years
xxx
Success Rate
2/7 ratings generated profit
Average Return
-53.19%
a xxx
rating ―
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 28.57% of your transactions generating a profit, with an average return of -53.19% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
CLRB Analyst Recommendation Trends
Rating
Nov 25
Dec 25
Jan 26
Feb 26
Mar 26
Strong Buy
0
0
0
0
2
Buy
0
0
0
0
0
Hold
3
3
1
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
3
3
1
0
2
Each month's total comprises the sum of three months' worth of ratings.
CLRB Financial Forecast
CLRB Stock Forecast FAQ
What is CLRB’s average 12-month price target, according to analysts?
Based on analyst ratings, Cellectar Biosciences’s 12-month average price target is 12.00.
What is CLRB’s upside potential, based on the analysts’ average price target?
Cellectar Biosciences has 264.74% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is CLRB a Buy, Sell or Hold?
Cellectar Biosciences has a consensus rating of Moderate Buy which is based on 2 buy ratings, 0 hold ratings and 0 sell ratings.
What is Cellectar Biosciences’s price target?
The average price target for Cellectar Biosciences is 12.00. This is based on 2 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $14.00 ,the lowest forecast is $10.00. The average price target represents 264.74% Increase from the current price of $3.29.
The highest analyst price target is $14.00 ,the lowest forecast is $10.00. The average price target represents 264.74% Increase from the current price of $3.29.
What do analysts say about Cellectar Biosciences?
Cellectar Biosciences’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 2 Wall Streets Analysts.
How can I buy shares of CLRB?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.